Quentin De Larochelambert, Andy Marc, Juliana Antero, Eric Le Bourg, Jean-François Toussaint: Covid-19 Mortality: A Matter of Vulnerability Among Nations Facing Limited Margins of Adaptation, in: Frontiers in Public Health, Vol. 8, Artikel 604339, November 2020.
Materials
17 posts
Arznei-Telegramm: Neu auf dem Markt. Covid-19-Impfstoff von Moderna, in: arznei-telegramm, No. 52 (January 22, 2021), pp. 1-4.
In this issue of arznei-telegramm, the authors deal with the Covid-19 vaccine from the company Moderna.
Arznei-Telegramm: Im Blickpunkt. Impfstoffe gegen Covid-19. Anlass zur Hoffnung oder unkalkulierbares Risiko?, in: arznei-telegramm Nr. 51 (18. Dezember 2020), pp. 89-92. (In Focus. Vaccines against Covid-19: Cause for hope or incalculable risk?).
In the December issue of arznei-telegramm, the authors of this article discussed the hopes for an effective vaccine that could help contain the pandemic, and the risks that these fast-track vaccines could pose.
BUKO Pharma-Kampagne (ed.): Nutzen von Covid-19 Impfungen. Wissensstand noch unbefriedigend, in: Pharma-Brief 10, December 2020. (Benefits of Covid-19 vaccinations. State of knowledge still unsatisfactory.)
In its article, BUKO Pharma-Kampagne addresses the issue of vaccines against the coronavirus.
“Several vaccines against covid-19 are close to approval or have already received emergency approval. But what do we even know about benefits and risks? The media reports high vaccine efficacy of 90% or more. The reports suggest that this means preventing severe disease and interrupting transmission of Covid-19. This is a misunderstanding, probably triggered by the fact that the figures circulating were based largely on brief press releases from the manufacturers, not on independently peer-reviewed scientific publications about the vaccines.”
World Bank Group (ed.): Poverty and Shared Prosperity 2020: Reversals of Fortune. Washington, DC: World Bank, 2020.
The Poverty and Shared Prosperity series provides a global audience with the latest and most accurate estimates on trends in global poverty and shared prosperity. For more than two decades, extreme poverty was steadily declining. Now, for the first time in a generation, the quest to end poverty has suffered its worst setback.
Peter Doshi: Will covid-19 vaccines save lives? Current trials aren’t designed to tell us, in: BMJ 2020;371:m4037 (21 October 2020).
Andrew Joseph: Actual Covid-19 case count could be 6 to 24 times higher than official estimates, CDC study shows, in: STAT, 21 July 2020.
A. Danielle Iuliano u.a.: Estimates of global seasonal influenza-associated respiratory mortality: a modelling study, in: The Lancet, Issue. 10127 (2018) Vol. 391, pp. 1285-1300.
John Paget and others: Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project, in: Journal of Global Health, No. 2 (December 2019) Vol. 9.
Final report of the “Heinsberg Study”
Hendrik Streeck and others: Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event, 4 May 2020
World Health Organisation (WHO): Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), 16-24 February 2020.
Office of National Statistics (London): Deaths registered weekly in England and Wales, provisional: week ending 10 April 2020 (21 April 2020).
Links to the website of the Santé publique France, where data and studies on the COVID-19 epidemic are continuously published (French).
Interim report by the Centro Nacional de Epidemiología (ISCIII) on mortality in Spain due to the Covid-19 pandemic, 4 April 2020 (Spanish).
Third Bulletin of the Italian Ministry of Health, 16 April 2020 (Italian).
Interim report by the University Hospital Bonn, 9 April 2020 (German).
Prof. Dr Hendrik Streeck, Prof. Dr Gunther Hartmann, Prof. Dr Martin Exner, Prof. Dr Matthias Schmid
Strategy paper of the german Federal Ministry of the Interior, Building and Homeland (Bundesministerium des Innern, Bau und Heimat, BMI), 18 March 2020, 17 pages (German).